首页 | 本学科首页   官方微博 | 高级检索  
     


Long‐term safety and treatment effects of cannabidiol in children and adults with treatment‐resistant epilepsies: Expanded access program results
Authors:Jerzy P. Szaflarski  Elizabeth Martina Bebin  Anne M. Comi  Anup D. Patel  Charuta Joshi  Daniel Checketts  Jules C. Beal  Linda C. Laux  Lisa M. De Boer  Matthew H. Wong  Merrick Lopez  Orrin Devinsky  Paul D. Lyons  Pilar Pichon Zentil  Robert Wechsler  CBD EAP study group
Affiliation:1. University of Alabama Birmingham, Birmingham, AL, USA;2. Kennedy Krieger Institute, Baltimore, MD, USA;3. Nationwide Children's Hospital, Columbus, OH, USA;4. University of Iowa Children's Hospital, Iowa City, IA, USA;5. GW Research Ltd, London, UK;6. Montefiore Medical Center and Albert Einstein College in Medicine, Bronx, NY, USA;7. Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, USA;8. Greenwich Biosciences Inc., Carlsbad, CA, USA;9. Wake Forest Baptist Medical Center, Winston‐Salem, NC, USA;10. Loma Linda University Children's Hospital, Loma Linda, CA, USA;11. NYU Langone's Comprehensive Epilepsy Center, New York, NY, USA;12. Virginia Comprehensive Epilepsy Program, Winchester, VA, USA;13. Consultants in Epilepsy & Neurology, PLLC and Idaho Comprehensive Epilepsy Center, Boise, ID, USA
Abstract:
Keywords:cannabidiol  efficacy  expanded access program  seizures  tolerability  treatment‐resistant epilepsy
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号